130 related articles for article (PubMed ID: 38534930)
21. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
[TBL] [Abstract][Full Text] [Related]
22. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Garland ML; Vather R; Bunkley N; Pearse M; Bissett IP
Int J Colorectal Dis; 2014 Mar; 29(3):301-7. PubMed ID: 24420737
[TBL] [Abstract][Full Text] [Related]
23. Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response.
Gahagan JV; Whealon MD; Phelan MJ; Mills S; Jafari MD; Carmichael JC; Stamos MJ; Zell JA; Pigazzi A
Surg Oncol; 2020 Mar; 32():35-40. PubMed ID: 31726418
[TBL] [Abstract][Full Text] [Related]
24. Exploring treatment outcomes in Stage II-III rectal cancer patients undergoing neoadjuvant therapy at a tertiary care center in Pakistan: a comprehensive analysis of pathological outcomes.
Soomro MY; Khan SR; Muhammad H; Ahmad S; Zehra N; Ali I; Samar MR; Hameed A; Moosajee M; Rashid YA
BMC Cancer; 2024 Apr; 24(1):479. PubMed ID: 38627736
[TBL] [Abstract][Full Text] [Related]
25. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ;
J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
[TBL] [Abstract][Full Text] [Related]
27. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
[TBL] [Abstract][Full Text] [Related]
28. Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
Yu S; Mamtani R; O'Hara MH; O'Dwyer PJ; Margalit O; Giantonio BJ; Shmueli E; Reiss KA; Boursi B
Clin Colorectal Cancer; 2021 Jun; 20(2):121-129. PubMed ID: 33608161
[TBL] [Abstract][Full Text] [Related]
29. Standard (8 weeks) vs long (12 weeks) timing to minimally-invasive surgery after NeoAdjuvant Chemoradiotherapy for rectal cancer: a multicenter randomized controlled parallel group trial (TiMiSNAR).
Monsellato I; Alongi F; Bertocchi E; Gori S; Ruffo G; Cassinotti E; Baldari L; Boni L; Pernazza G; Pulighe F; De Nisco C; Perinotti R; Morpurgo E; Contardo T; Mammano E; Elmore U; Delpini R; Rosati R; Perna F; Coratti A; Menegatti B; Gentilli S; Baroffio P; Buccianti P; Balestri R; Ceccarelli C; Torri V; Cavaliere D; Solaini L; Ercolani G; Traverso E; Fusco V; Rossi M; Priora F; Numico G; Franzone P; Orecchia S
BMC Cancer; 2019 Dec; 19(1):1215. PubMed ID: 31842784
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
[TBL] [Abstract][Full Text] [Related]
31. Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer: A Comparison of Short- and Long-term Oncologic Outcomes.
Goffredo P; Khan A; Mott SL; Jensen CC; Madoff RD; Gaertner WB; You YN; Hassan I
Ann Surg; 2022 Dec; 276(6):e819-e824. PubMed ID: 34353995
[TBL] [Abstract][Full Text] [Related]
32. Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer.
Peng J; Lin J; Qiu M; Wu X; Lu Z; Chen G; Li L; Ding P; Gao Y; Zeng Z; Zhang H; Wan D; Pan Z
Clinics (Sao Paulo); 2016 Aug; 71(8):449-54. PubMed ID: 27626475
[TBL] [Abstract][Full Text] [Related]
33. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma.
Jia AY; Narang A; Safar B; Zaheer A; Murphy A; Azad NS; Gearhart S; Fang S; Efron J; Warczynski T; Hacker-Prietz A; Meyer J
Radiat Oncol; 2019 Aug; 14(1):147. PubMed ID: 31426827
[TBL] [Abstract][Full Text] [Related]
34. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
35. [Application of short-course radiotherapy with total neoadjuvant therapy in the treatment of middle and low rectal cancer].
Chen CJ; Yang CK; Jian JL; Guan S; Xie MM
Zhonghua Yi Xue Za Zhi; 2023 Jan; 103(4):271-277. PubMed ID: 36660788
[No Abstract] [Full Text] [Related]
36. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Neoadjuvant Rectal Cancer (NAR) Score for Prognostication Following Total Neoadjuvant Therapy (TNT) for Locally Advanced Rectal Cancer.
Shah S; Asawa P; Abel S; Wegner RE
J Gastrointest Cancer; 2023 Sep; 54(3):829-836. PubMed ID: 36253514
[TBL] [Abstract][Full Text] [Related]
38. Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
Huntington CR; Boselli D; Symanowski J; Hill JS; Crimaldi A; Salo JC
Ann Surg Oncol; 2016 Mar; 23(3):877-87. PubMed ID: 26514119
[TBL] [Abstract][Full Text] [Related]
39. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of clinical predictive factors of pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Yu T; Cao XL; Wu GJ; Zhao G; Jia WW; Xiao G; Wang X
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1274-7. PubMed ID: 27122460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
